Rade, Michael
Kreuz, Markus
Borkowetz, Angelika
Sommer, Ulrich
Blumert, Conny
Füssel, Susanne
Bertram, Catharina
Löffler, Dennis
Otto, Dominik J.
Wöller, Livia A.
Schimmelpfennig, Carolin
Köhl, Ulrike
Gottschling, Ann-Cathrin
Hönscheid, Pia
Baretton, Gustavo B.
Wirth, Manfred
Thomas, Christian
Horn, Friedemann
Reiche, Kristin http://orcid.org/0000-0002-4452-4872
Funding for this research was provided by:
Fraunhofer Future Foundation
EFRE grants from the EU
Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Article History
Received: 11 July 2023
Accepted: 22 January 2024
First Online: 1 February 2024
Declarations
:
: The Internal Review Board at the Technische Universität Dresden (EK194092004, EK59032007) approved the study, and all patients gave written informed consent.
: Not applicable.
: Application EP 21719147.7 based on application PCT/EP2021/060092 with priority date of 20/Apr/2020: MULTI-GENE EXPRESSION ASSAY FOR PROSTATE CARCINOMA; date of application: 16/Nov/2022.